WAVE Life Sciences Ltd (NAS:WVE)
$ 5.74 0.22 (3.99%) Market Cap: 716.00 Mil Enterprise Value: 590.91 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 63/100

WAVE Life Sciences Ltd at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2020 / 10:00PM GMT
Release Date Price: $7.68 (+3.50%)
Martin Douglas Auster;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Great. Hey, everyone, thanks for joining us. I'm Marty Auster, one of the SMid-Cap Biotech Analyst here at Crédit Suisse. Thanks for joining us at our 29th Annual Healthcare Conference. I have got Wave Life Sciences' CEO, Paul Bolno, to make a presentation on Wave.

Paul, I'll hand it over to you. Thanks for joining us today. Have a fun presentation.

Paul B. Bolno
Wave Life Sciences Ltd. - President, CEO & Director

Marty, thank you so much for having us at the conference today, and we look forward to the opportunity to share more. And with that, before we begin -- there we go. We'll, obviously, be making forward-looking statements during this presentation. So I will refer everyone to our SEC filings for updates. But we're excited to be here. And we're excited to be here because there's a lot going on at Wave as we started out the year and continue on our progress to building a leading-genetic medicines company.

Our foundational work

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot